BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $87,000 | -84.8% | 16,600 | -75.6% | 0.00% | -87.5% |
| Q1 2017 | $572,000 | -26.7% | 68,097 | -61.5% | 0.01% | -33.3% |
| Q3 2016 | $780,000 | +107.4% | 176,962 | +33.8% | 0.01% | +100.0% |
| Q2 2016 | $376,000 | +548.3% | 132,288 | +544.3% | 0.01% | +500.0% |
| Q1 2016 | $58,000 | -97.2% | 20,533 | -85.0% | 0.00% | -96.2% |
| Q2 2015 | $2,046,000 | +503.5% | 137,042 | +265.3% | 0.03% | +420.0% |
| Q1 2015 | $339,000 | +5.6% | 37,517 | +14.4% | 0.01% | +25.0% |
| Q3 2014 | $321,000 | -69.5% | 32,797 | -60.3% | 0.00% | -69.2% |
| Q2 2014 | $1,052,000 | – | 82,546 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |